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SHORT COMMUNICATION
Splanchnic blood flow changes in the presence of hepatic tumour: evidence
of a humoral mediator
R. Carter, J.H. Anderson, T.G. Cooke, J.N. Baxter & W.J. Angerson
University Department ofSurgery, Glasgow Royal Infirmary, Alexandra Parade, Glasgow G31 2ER, UK.
Summary Intrahepatic tumour is associated with alterations in splanchnic haemodynamics. To investigate the
hypothesis that these are the result of a circulating vasoactive agent, rat small bowel segments were
cross-perfused with arterial blood from groups (n = 12) of paired tumour-bearing (intrahepatic HSN sarcoma)
and control rats. The vascular resistance of the segment was significantly greater during perfusion by
tumour-bearing animals (91.6 mmHgml-' min, s.e. 21.5, vs 51.7 mmHg ml-'min, s.e. 7.4, P<0.05), sugges-
ting that intrahepatic tumour may be associated with a circulating vasoactive agent. A similar mechanism may
underlie changes in the hepatic perfusion index in patients with liver metastases.
There has been interest for several years in the haemo-
dynamic changes that accompany the development of liver
metastases from colorectal carcinoma, and their potential
role-in identifying patients with occult metastatic disease. In
1985, Leveson et al. reported that the hepatic perfusion index
(HPI), the ratio of hepatic arterial to total liver blood flow as
measured by dynamic scintigraphy, was abnormally elevated
in patients with colorectal liver metastases. This occurred
both in patients with overt metastases and in those who,
despite having an ostensibly normal liver at the time of
primary surgery, manifested hepatic tumour within 1 year of
follow-up. We have recently confirmed these findings using
the more direct and quantitative technique of duplex ultra-
sonography (Leen et al., 1991; 1993a).
The mechanisms underlying this effect are unknown. Liver
metastases derive their blood supply predominantly from
the hepatic artery (Breedis & Young, 1954), and initially it
was assumed that the primary change was an increase in
hepatic arterial flow to meet demand from rapidly growing
tumour tissue. Quantitative flowmetry has confirmed that
hepatic arterial flow is increased, but has shown that a
substantial reduction in portal venous blood flow also con-
tributes to the elevation of the perfusion index (Leen et al.,
1991). Experiments in rat liver tumour models have demon-
strated a similar rise in the HPI that is due entirely to
reduced portal venous inflow secondary to increased splan-
chnic vascular resistance (Nott et al., 1989; Hemingway et al.,
1991; 1993). This suggests that the means by which the
tumour influences hepatic haemodynamics may not be purely
local in nature. In the present study we cross-perfused nor-
mal rat bowel segments with blood from tumour-bearing and
control rats, to investigate the hypothesis that the increase in
splanchnic vascular resistance is due to a circulating vasoac-
tive agent.
Materials and methods
Tumour was induced in male hooded Lister rats (200-250 g)
by bilobar intrahepatic injection of 106 HSN sarcoma cells.
Experiments were performed 3 weeks later, when discrete
tumours were apparent. In a given experiment, one such
animal, together with a weight-matched normal control rat,
provided arterial blood to perfuse the intestine of a third
(normal) rat.
The experimental arrangement is shown in Figure 1. All
three animals were anaesthetised with intraperitoneal sodium
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pentobarbitone (30 mg kg-') and heparinised (200 units 100
g-'). The bowel segment, incorporating the entire jejunum
and ileum, was isolated as described by Anzueto et al. (1984).
It was perfused via the superior mesenteric artery, which was
connected to the retrogradely cannulated carotid artery of
either the tumour-bearing or control animal. A multiway
connector in the arterial circuit allowed rapid switching
between the two perfusing animals and the monitoring of
arterial pressure. The segment was drained by a portal
venous cannula into a reservoir, from which it was returned
to the jugular vein of the perfusing animal by a pump.
Separate reservoirs were maintained for each of the two
perfusing animals, and these were primed with heparinised
blood taken from separate tumour-bearing and normal rats.
Wide-bore cannulae (2 mm internal diameter), tapered at the
tip where necessary, were used throughout to minimise resis-
tance to flow.
The bowel segment was perfused sequentially by the
tumour-bearing and control animals in random order. A
5 min equilibration period was allowed before each flow
measurement, which was performed by collecting the segmen-
tal venous outflow over three 30 s periods, each 90 s apart.
The vascular resistance of the segment was calculated by
dividing the mean arterial pressure by the segmental blood
flow. Results were accepted only when animals had a
physiological temperature, electrolytes, blood gases and
acid-base balance and a minimum mean arterial pressure of
80 mmHg. A total of 12 technically acceptable experiments
were performed. Seven other experiments were terminated
because of physiological instability or death of one of the
animals, or because no flow could be obtained through the
segment despite the use of heparin. Although at least two
pairs of flow measurements were performed in each experi-
ment, only the first pair was regarded as definitive because of
the subsequent mixing of blood. The significance of the
observed differences for the paired data was assessed using
the Wilcoxon rank sum test.
Results
Mean systolic pressure was similar in tumour-bearing
(100.6 mmHg, s.e. 2.5) and control animals (101.6 mmHg,
s.e. 1.8). The mean flow through the segments was less during
perfusion by tumour-bearing animals (1.70 mlmin-', s.e.
0.28) than by control animals (2.43 ml min-', s.e. 0.25), but
not significantly so (P = 0.12). The splanchnic vascular resis-
tance was significantly greater during perfusion by tumour-
bearing animals (91.6 mmHgml-' min, s.e. 21.5, vs 51.7
mmHgml'min, s.e. 7.41, P = 0.036) (Figure 2). As long as
perfusion pressure remained stable, the differences in flow
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Figure 1 Isolated small bowel segment cross-perfused by either tumour-bearing or control animals.
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Figure 2 Paired segmental vascular resistance values for per-
fusion by tumour-bearing and control animals.
observed initially were reproducible in subsequent measure-
ments.
Discussion
An increase in the hepatic perfusion index has been demon-
strated in number of experimental liver tumour models, and
this has been shown to be due to a reduction in portal
venous inflow associated with increased gastrointestinal vas-
cular resistance (Nott et al., 1989; Hemingway et al., 1991;
1993). The results of the present experiment suggest that, in
the HSN sarcoma model, this is at least partly mediated by a
circulating agent. Whether this is a tumour product or an
endogenous agent remains unclear, and we are currently
undertaking further studies to identify it.
The haemodynamic changes underlying the increase in the
HPI in patients with liver metastases consist of both a reduc-
tion in portal venous blood flow and an increase in hepatic
arterial flow (Leen et al., 1991). The latter feature does not
appear to be reproduced in experimental models for reasons
that are unknown. However, the available evidence is consis-
tent with the hypothesis that the reduction in portal flow is
humorally mediated in patients as in the experimental setting.
Haemodynamic derangement is detectable in patients with a
very small hepatic tumour burden and is little affected by
resection of the primary colorectal tumour. Also, comparison
of the portal venous congestive index (ratio of cross-sectional
area to blood velocity) in patients with liver metastases and
those with hepatic cirrhosis suggests that the reduction in
portal flow in the former is due to increased gastrointestinal
rather than intrahepatic vascular resistance (Leen et al.,
1993b). The existence of a humoral mediator would raise the
possibility of biochemical detection of micrometastic disease.
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